IDF general


UN Summit on NCDs

National Diabetes Programmes

Diabetes and oral health - information for health professionals

Diabetes and oral health - information for the public

Individual country assessments

Among the aims of the International Diabetes Federation’s (IDF) Task Force is to help ensure access to insulin and other essential diabetes supplies to people with diabetes. In order to address situations where chronic problems exist with regards to the availability of and access to proper diabetes care it is important to better understand what the barriers to access are.

Sleep apnoea and type 2 diabetes

Recent research demonstrates the likelihood of a relationship between type 2 diabetes and obstructive sleep apnoea (OSA), the most common form of sleep disordered breathing. The IDF consensus statement on sleep apnoea and type 2 diabetes wants to raise awareness of the association between the two conditions, which have significant implications on public health and on the lives of individuals.
A few facts:

IDF Centres of Education

IDF Centres of Education (IDFCE), selected by IDF, form a voluntary network to improve access to interdisciplinary diabetes education for health care professionals and strengthen regional capacity to respond to the diabetes epidemic.

The goals of the IDFCE are to:

Diabetes and oral health

The World Dental Federation (FDI) and the International Diabetes Federation (IDF) jointly organised a symposium on Oral Health and Diabetes* on 25 October 2007 during the FDI Annual World Dental Congress in Dubai, UAE.  The presenting experts and all participants welcomed the initiative of the two convening organisations to emphasize the interrelationship between diabetes and oral health.

Guideline for Management of Postmeal Glucose 2007

HbA1c Working Group

The measurement of glycated haemoglobin (HbA1c) is central to diabetes care. This is a measure by which healthcare providers can relate blood glucose control to the risk of complications, such as eye damage or kidney failure. However, a lack of standardization in the methods used to measure glycated haemoglobin has produced wide variations among results and is among the current limitations to the effective use of HbA1c results in gauging a person's risk of these complications.